Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PARP inhibition in UV-associated angiosarcoma preclinical models.
Weidema ME, Desar IME, Hillebrandt-Roeffen MHS, van Erp AEM, Masuzawa M; PALGA-group; Flucke UE, van der Graaf WTA, Versleijen-Jonkers YMH. Weidema ME, et al. Among authors: masuzawa m. J Cancer Res Clin Oncol. 2021 Sep;147(9):2579-2590. doi: 10.1007/s00432-021-03678-4. Epub 2021 Jun 3. J Cancer Res Clin Oncol. 2021. PMID: 34085099 Free PMC article.
NUP160-SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma.
Shimozono N, Jinnin M, Masuzawa M, Masuzawa M, Wang Z, Hirano A, Tomizawa Y, Etoh-Kira T, Kajihara I, Harada M, Fukushima S, Ihn H. Shimozono N, et al. Among authors: masuzawa m. Cancer Res. 2015 Nov 1;75(21):4458-65. doi: 10.1158/0008-5472.CAN-15-0418. Cancer Res. 2015. PMID: 26527604
Survivin: A novel marker and potential therapeutic target for human angiosarcoma.
Tsuneki M, Kinjo T, Mori T, Yoshida A, Kuyama K, Ohira A, Miyagi T, Takahashi K, Kawai A, Chuman H, Yamazaki N, Masuzawa M, Arakawa H. Tsuneki M, et al. Among authors: masuzawa m. Cancer Sci. 2017 Nov;108(11):2295-2305. doi: 10.1111/cas.13379. Epub 2017 Sep 15. Cancer Sci. 2017. PMID: 28845553 Free PMC article.
PDK1 is a potential therapeutic target against angiosarcoma cells.
Wada M, Horinaka M, Yasuda S, Masuzawa M, Sakai T, Katoh N. Wada M, et al. Among authors: masuzawa m. J Dermatol Sci. 2015 Apr;78(1):44-50. doi: 10.1016/j.jdermsci.2015.01.015. Epub 2015 Feb 7. J Dermatol Sci. 2015. PMID: 25726712
Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
Chan JY, Lim JQ, Yeong J, Ravi V, Guan P, Boot A, Tay TKY, Selvarajan S, Md Nasir ND, Loh JH, Ong CK, Huang D, Tan J, Li Z, Ng CC, Tan TT, Masuzawa M, Sung KW, Farid M, Quek RHH, Tan NC, Teo MCC, Rozen SG, Tan P, Futreal A, Teh BT, Soo KC. Chan JY, et al. Among authors: masuzawa m. J Clin Invest. 2020 Nov 2;130(11):5833-5846. doi: 10.1172/JCI139080. J Clin Invest. 2020. PMID: 33016928 Free PMC article.
Strong radioprotective FGF1 signaling down-regulates proliferative and metastatic capabilities of the angiosarcoma cell line, ISOS-1, through the dual inhibition of EGFR and VEGFR pathways.
Miura T, Fujita M, Kawano M, Imadome K, Yasuda T, Nishihara S, Imamura T, Masuzawa M, Imai T, Nakayama F. Miura T, et al. Among authors: masuzawa m. Clin Transl Radiat Oncol. 2017 Nov 4;7:83-90. doi: 10.1016/j.ctro.2017.10.006. eCollection 2017 Dec. Clin Transl Radiat Oncol. 2017. PMID: 29594234 Free PMC article.
179 results